Literature DB >> 14662961

New methods to assess susceptibilities of Aspergillus isolates to caspofungin.

Alexander Imhof1, S Arunmozhi Balajee, Kieren A Marr.   

Abstract

Echinocandins are a group of antifungal agents that target 1,3-beta-glucan synthase, causing disruption of mold growth at cells compromising tips and branch points. In part because echinocandins do not induce clear growth inhibition end points using broth dilution techniques, methods to test susceptibility have not yet been standardized. We developed a novel susceptibility assay that measures growth of Aspergillus species on solid agar media that contain serial dilutions of caspofungin (agar dilution). Results of agar dilution testing of multiple isolates were compared to results obtained by broth microdilution (MIC), microscopic evaluation (minimal effective concentration [MEC]), and a new method to measure fungal burden, quantification of secreted hyphal antigen. MICs obtained by the agar dilution method were within 1 dilution of MECs for 85% of the Aspergillus isolates; the highest agreement was observed for isolates of Aspergillus niger (95%), which were particularly susceptible to caspofungin. Agar dilution MICs were also consistent with those obtained by quantifying antigen secretion. MICs obtained by broth microdilution were different than MICs by any other method. Several Aspergillus isolates with decreased susceptibility to caspofungin were identified. Agar dilution is simple and reproducible, and results were consistent with the results of more technically demanding techniques. This method may be appropriate for use in the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662961      PMCID: PMC309030          DOI: 10.1128/JCM.41.12.5683-5688.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates.

Authors:  Sevtap Arikan; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 2.  Antifungal chemotherapy: advances and perspectives.

Authors:  Andreas H Groll; Thomas J Walsh
Journal:  Swiss Med Wkly       Date:  2002-06-15       Impact factor: 2.193

3.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.

Authors:  C M Douglas; J A D'Ippolito; G J Shei; M Meinz; J Onishi; J A Marrinan; W Li; G K Abruzzo; A Flattery; K Bartizal; A Mitchell; M B Kurtz
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

5.  Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Andreas H Groll; Kristin Roussillon; Melissa Hemmings; Caron A Lyman; Tin Sein; John Bacher; Ihor Bekersky; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.

Authors:  María del Carmen Serrano; Anastasio Valverde-Conde; Mónica Chávez M; Samuel Bernal; Rosa María Claro; Javier Pemán; Mercedes Ramirez; Estrella Martín-Mazuelos
Journal:  Diagn Microbiol Infect Dis       Date:  2003-02       Impact factor: 2.803

8.  Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.

Authors:  Nir Osherov; Gregory S May; Nathaniel D Albert; D P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).

Authors:  Ana Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.

Authors:  Itamar Shalit; Yona Shadkchan; Zmira Samra; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  12 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.

Authors:  Ying-qiu Bao; Zhe Wan; Ruo-yu Li
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

3.  Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy.

Authors:  R Plummer; J Bodkin; D Power; N Pantarat; W A Bubb; P W Kuchel; T C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

4.  Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.

Authors:  Santosh K Katiyar; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 5.  Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.

Authors:  A Mayr; Cornelia Lass-Flörl
Journal:  Eur J Med Res       Date:  2011-04-28       Impact factor: 2.175

6.  Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.

Authors:  Louise A Walker; Keunsook K Lee; Carol A Munro; Neil A R Gow
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 7.  Methods for in vitro evaluating antimicrobial activity: A review.

Authors:  Mounyr Balouiri; Moulay Sadiki; Saad Koraichi Ibnsouda
Journal:  J Pharm Anal       Date:  2015-12-02

8.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495

9.  Multiresistance to Nonazole Fungicides in Aspergillus fumigatus TR34/L98H Azole-Resistant Isolates.

Authors:  I Gonzalez-Jimenez; R Garcia-Rubio; S Monzon; J Lucio; I Cuesta; E Mellado
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity.

Authors:  Vanessa Duncan; Daniel Smith; Laura Simpson; Emma Lovie; Laura Katvars; Leon Berge; Jennifer Robertson; Shane Smith; Carol Munro; Derry Mercer; Deborah O'Neil
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.